Indexed In
- Open J Gate
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- Centre for Agriculture and Biosciences International (CABI)
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- CABI full text
- Publons
- Geneva Foundation for Medical Education and Research
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Amal A Qaisi
Health Directorate of Jazan Health, Kingdom of Saudi Arabia
Publications
-
Case Report
Sickle Cell Disease (SCD) and COVID-19: Case Series
Author(s): Awaji Q Al-Naami, Liaqat Ali Khan*, Faisal I Zaidan, Hussam M Halawi, Laila E Asiri, Taher A Sumaili, Amal A Qaisi, Ibrahim A Al-Naami and Turki M Darweesh
The ongoing pandemic of COVID-19 that started in the Hubei province of China in late December 2019, caused by severe acute respiratory syndrome corona virus-2 (SARS CoV-2). Globally millions affected by the disease so far. The risk of COVID-19 severity and its complications increases with age and other comorbidities. The course of SARS-CoV-2 infection or its related complications has yet to be established in patients with sickle cell disease (SCD), once more evidence is available. It is clear from the available data that the course of COVID-19 in patients with SCD is mild to moderate, seldom severe, and rarely fatal. Herein we report three known cases of SCD with confirmed COVID-19, in whom the course of the disease was mild to moderate and uncomplicated with uneventful recoveries. .. View more»